Cargando…
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial
INTRODUCTION: Circulating prostaglandin E(2) levels are elevated in acutely decompensated cirrhosis and have been shown to contribute to immune suppression. Albumin binds to and inactivates this immune-suppressive lipid mediator. Human albumin solution (HAS) could thus be repurposed as an immune-res...
Autores principales: | China, Louise, Skene, Simon S, Bennett, Kate, Shabir, Zainib, Hamilton, Roseanna, Bevan, Scott, Chandler, Torsten, Maini, Alexander A, Becares, Natalia, Gilroy, Derek, Forrest, Ewan H, O’Brien, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196858/ https://www.ncbi.nlm.nih.gov/pubmed/30344180 http://dx.doi.org/10.1136/bmjopen-2018-023754 |
Ejemplares similares
-
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial
por: China, Louise, et al.
Publicado: (2016) -
Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial
por: China, Louise, et al.
Publicado: (2018) -
Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review
por: Härmälä, Suvi, et al.
Publicado: (2019) -
Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease
por: China, Louise, et al.
Publicado: (2018) -
PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial
por: Woodhouse, Charlotte Alexandra, et al.
Publicado: (2019)